JFGIW
SUPN icon

Johnson Financial Group Inc (Wisconsin)’s Supernus Pharmaceuticals SUPN Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-149
Closed -$5.72K – 947
2024
Q4 		$5.72K Sell
149
-40
-21% -$1.41K ﹤0.01% 709
2024
Q3 		$5.89K Buy
+189
New +$5.9K ﹤0.01% 759

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s SUPN Position: Q1 2025 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Supernus Pharmaceuticals (SUPN) in Q1 2025, closing a stake of 149 shares — an estimated $5.72K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in SUPN in Q3 2024 and held it in 2 quarters. The position peaked at $5.89K in Q3 2024. 295 funds tracked by Wall St. Rank hold SUPN as of Q1 2025.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Supernus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 149 Supernus Pharmaceuticals shares in Q1 2025, an estimated $5.72K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Supernus Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Supernus Pharmaceuticals position peaked at $5.89K in Q3 2024.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2025.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2025, filed 15 May 2025.